Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2010

01-07-2010 | Original Article

What Is Most Important to Patients when Deciding about Colorectal Screening?

Authors: Avlin Imaeda, MD, PhD, Danielle Bender, MD, Liana Fraenkel, MD, MPH

Published in: Journal of General Internal Medicine | Issue 7/2010

Login to get access

Abstract

BACKGROUND

Colorectal cancer (CRC) screening can be administered through tests with varied characteristics and is a preference-sensitive decision.

OBJECTIVE

To assess patient experiences with a Maximum Differences Scaling (MDS) tool for eliciting values about CRC screening test characteristics and determine whether patients vary in how they prioritize test characteristics and whether this variation relates to test preferences.

DESIGN

MDS survey to elicit patients’ values for characteristics related to fecal occult blood testing, sigmoidoscopy, colonoscopy, CT colonography and colon capsule endoscopy.

PARTICIPANTS

92 patients enrolled in primary care clinics at a VA hospital and associated university.

RESULTS

Patients reported that the tool was easy to use (95%). On completion 62% would choose colonoscopy, 23% colon capsule endoscopy and 10% CT colonography. Of the attributes evaluated, patients valued sensitivity, risk of tear and need for a second test most. Sensitivity was more important to those choosing colonoscopy than those choosing other tests (median importance = 21.5 versus 19.6, p < 0.01). Concern with complications and sedation was positively associated with age (p < 0.001 and p < 0.001), whereas concern with colon preparation and missing work was negatively associated with age (p < 0.009 and p < 0.03). Patients with fair or poor health status were less concerned with sensitivity than patients in good to excellent health (median importance = 19.3 versus 21.4, p < 0.008).

CONCLUSIONS

This pilot study suggests that patients vary in how they prioritize colorectal cancer screening test attributes; this variation is associated with test preferences, and this MDS tool is feasible to use and may help patients construct their preferences.
Appendix
Available only for authorised users
Literature
1.
go back to reference Beauchamp T, Childress J. Principles of Biomedical Ethics. New York: Oxford University Press; 1983. Beauchamp T, Childress J. Principles of Biomedical Ethics. New York: Oxford University Press; 1983.
2.
go back to reference Allicock M, Sandelowski M, DeVellis B, Campbell M. Variations in meanings of the personal core value "Health". Patient Educ Counsel. 2008;73:347–53.CrossRef Allicock M, Sandelowski M, DeVellis B, Campbell M. Variations in meanings of the personal core value "Health". Patient Educ Counsel. 2008;73:347–53.CrossRef
3.
go back to reference Reyna V. A theory of medical decision making and health: fuzzy trace theory. Med Decis Making. 2008;28:850–65.CrossRefPubMed Reyna V. A theory of medical decision making and health: fuzzy trace theory. Med Decis Making. 2008;28:850–65.CrossRefPubMed
4.
go back to reference Mandel J, Bond J, Church T, for the Minnesota colon cancer control study, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–71.CrossRefPubMed Mandel J, Bond J, Church T, for the Minnesota colon cancer control study, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–71.CrossRefPubMed
5.
go back to reference Kronborg O, Fenger C, Olsen J, Jorgensen O, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71.CrossRefPubMed Kronborg O, Fenger C, Olsen J, Jorgensen O, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71.CrossRefPubMed
6.
go back to reference Hardcastle J, Chamberlain J, Robinson M, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7.CrossRefPubMed Hardcastle J, Chamberlain J, Robinson M, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7.CrossRefPubMed
7.
go back to reference Winawer S, Zauber A, Ho M, The National Polyp Study Group, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–81.CrossRefPubMed Winawer S, Zauber A, Ho M, The National Polyp Study Group, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–81.CrossRefPubMed
8.
go back to reference Newcomb P, Norfleet R, Storer B, Surawicz T, Marcus P. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572–5.CrossRefPubMed Newcomb P, Norfleet R, Storer B, Surawicz T, Marcus P. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572–5.CrossRefPubMed
9.
go back to reference Muller A, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. Arch Intern Med. 1995;155:1741–48.CrossRefPubMed Muller A, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. Arch Intern Med. 1995;155:1741–48.CrossRefPubMed
10.
go back to reference Selby J, Friedman G, Quesenberry C, Weiss N. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–7.PubMedCrossRef Selby J, Friedman G, Quesenberry C, Weiss N. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–7.PubMedCrossRef
12.
13.
go back to reference Eliakim R, Fireman Z, Gralnek I, et al. Evaluation of the PillCam™ Colon capsule in the detection of colonic pathology: results of the first multicenter, prospective, comparative study. Endoscopy. 2006;38:963–70.CrossRefPubMed Eliakim R, Fireman Z, Gralnek I, et al. Evaluation of the PillCam™ Colon capsule in the detection of colonic pathology: results of the first multicenter, prospective, comparative study. Endoscopy. 2006;38:963–70.CrossRefPubMed
14.
go back to reference Schoofs N, Deviere J, Van Gossun A. PillCam™ colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective pilot study. Endoscopy. 2006;38:971–7.CrossRefPubMed Schoofs N, Deviere J, Van Gossun A. PillCam™ colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective pilot study. Endoscopy. 2006;38:971–7.CrossRefPubMed
15.
go back to reference Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med. 1999;14:432–7.CrossRefPubMed Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med. 1999;14:432–7.CrossRefPubMed
16.
go back to reference Pignone M. Patient preferences for colon cancer screening: the role of out-of-pocket costs. Am J Managed Care. 2007;13:390–92. Pignone M. Patient preferences for colon cancer screening: the role of out-of-pocket costs. Am J Managed Care. 2007;13:390–92.
17.
go back to reference Schroy P, Lal S, Glick J, Robinson P, Zamor P, Heerem T. Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Managed Care. 2007;13:393–400. Schroy P, Lal S, Glick J, Robinson P, Zamor P, Heerem T. Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Managed Care. 2007;13:393–400.
18.
go back to reference Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med. 2000;133:761–69.PubMed Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med. 2000;133:761–69.PubMed
19.
go back to reference Dolan N, Frisina S. Randomized controlled trial of a patient decision aid for colorectal cancer screening. Med Decis Making. 2002;22:125–39.PubMed Dolan N, Frisina S. Randomized controlled trial of a patient decision aid for colorectal cancer screening. Med Decis Making. 2002;22:125–39.PubMed
20.
go back to reference Griffith J, Lewis C, Brenner A, Pignone M. The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform and Decis Making. 2008;8:4–9.CrossRef Griffith J, Lewis C, Brenner A, Pignone M. The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform and Decis Making. 2008;8:4–9.CrossRef
21.
go back to reference Griffith J, Fichter M, Fowler F, Lewis C, Pignone M. Should a colon cancer screening decision aid include the option of no testing? A comparative trial of two decision aids. BMC Med Inform and Decis Making. 2008;8:10–9.CrossRef Griffith J, Fichter M, Fowler F, Lewis C, Pignone M. Should a colon cancer screening decision aid include the option of no testing? A comparative trial of two decision aids. BMC Med Inform and Decis Making. 2008;8:10–9.CrossRef
22.
go back to reference Kim J, Whitney A, Hayter S, et al. Development and initial testing of a computer-based patient decision aid to promote colorectal cancer screening for primary care practice. BMC Med Inform and Decis Making. 2005;5:36–47.CrossRef Kim J, Whitney A, Hayter S, et al. Development and initial testing of a computer-based patient decision aid to promote colorectal cancer screening for primary care practice. BMC Med Inform and Decis Making. 2005;5:36–47.CrossRef
23.
go back to reference Ruffin M, Fetters P, Jimbo M. Preference-based electronic decision aid to promote colorectal cancer screening: Results of a randomized controlled trial. Prevent Med. 2007;45:267–73.CrossRef Ruffin M, Fetters P, Jimbo M. Preference-based electronic decision aid to promote colorectal cancer screening: Results of a randomized controlled trial. Prevent Med. 2007;45:267–73.CrossRef
24.
go back to reference Van Dam L, Hol L, Bekker-Grob E, et al. What determines individuals’ preferences for colorectal cancer screening programmes? A discrete choice experiment. Eur J Cancer 2009;(2009). doi:10.1016/j.ejca.2009.07.014. Van Dam L, Hol L, Bekker-Grob E, et al. What determines individuals’ preferences for colorectal cancer screening programmes? A discrete choice experiment. Eur J Cancer 2009;(2009). doi:10.​1016/​j.​ejca.​2009.​07.​014.
25.
go back to reference Hawley S, Volk R, Krishnamurthy P, Jibaja-Weiss M, Vernon S, Kneuper S. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 2008;46:S10–6.CrossRefPubMed Hawley S, Volk R, Krishnamurthy P, Jibaja-Weiss M, Vernon S, Kneuper S. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 2008;46:S10–6.CrossRefPubMed
26.
go back to reference Marshall D, Johnson F, Phillips K, Marshall J, Thabane L, Kulin N. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007;10:415–30.CrossRefPubMed Marshall D, Johnson F, Phillips K, Marshall J, Thabane L, Kulin N. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007;10:415–30.CrossRefPubMed
27.
go back to reference Dolan J. Patient priorities in colorectal cancer screening decisions. Health Expect. 2005;8:334–44.CrossRefPubMed Dolan J. Patient priorities in colorectal cancer screening decisions. Health Expect. 2005;8:334–44.CrossRefPubMed
28.
go back to reference U.S Preventative Services Task Force USPST. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627–37. U.S Preventative Services Task Force USPST. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627–37.
29.
go back to reference Louviere, J. The best-worst or maximum difference measurement model: Applications to behavioral research in marketing. The American Marketing Association's Behavioral Research Conference Phoenix, Arizona 1993. Louviere, J. The best-worst or maximum difference measurement model: Applications to behavioral research in marketing. The American Marketing Association's Behavioral Research Conference Phoenix, Arizona 1993.
30.
go back to reference Flynn T, Louviere J, Peters T, Coast J. Estimating preferences for a dermatology consultation using Best-Worst Scaling: comparison of various methods of analysis. BMC Med Res Methodol. 2008;8:76–88.CrossRefPubMed Flynn T, Louviere J, Peters T, Coast J. Estimating preferences for a dermatology consultation using Best-Worst Scaling: comparison of various methods of analysis. BMC Med Res Methodol. 2008;8:76–88.CrossRefPubMed
34.
go back to reference Fraenkel L, Bogardus S, Concato J, Felson D, Wittink D. Patient preferences for treatment of rheumatoid arthritis. Ann Rheum Dis. 2004;63:1372–8.CrossRefPubMed Fraenkel L, Bogardus S, Concato J, Felson D, Wittink D. Patient preferences for treatment of rheumatoid arthritis. Ann Rheum Dis. 2004;63:1372–8.CrossRefPubMed
35.
go back to reference Longacre A, Imaeda A, Garcia-Tsao G, Fraenkel L. A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. Hepatology. 2008;47:169–76.CrossRefPubMed Longacre A, Imaeda A, Garcia-Tsao G, Fraenkel L. A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. Hepatology. 2008;47:169–76.CrossRefPubMed
36.
go back to reference DeBourcy A, Lichtenberger S, Felton S, Butterfield K, Ahnen D, Denberg T. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2007;23:169–74.CrossRefPubMed DeBourcy A, Lichtenberger S, Felton S, Butterfield K, Ahnen D, Denberg T. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2007;23:169–74.CrossRefPubMed
37.
go back to reference Almog R, Ezra G, Lavi I, Rennert G, Hagoel L. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prevent. 2008;17:430–37.CrossRef Almog R, Ezra G, Lavi I, Rennert G, Hagoel L. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prevent. 2008;17:430–37.CrossRef
38.
go back to reference Ling B, Moskowitz M, Wachs D, Pearson B, Schroy P. Attitudes toward colorectal cancer screening tests. A survey of patients and physicians. J Gen Intern Med. 2001;16:822–30.CrossRefPubMed Ling B, Moskowitz M, Wachs D, Pearson B, Schroy P. Attitudes toward colorectal cancer screening tests. A survey of patients and physicians. J Gen Intern Med. 2001;16:822–30.CrossRefPubMed
39.
go back to reference Leard L, Savides T, Ganiats T. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45:211–18.PubMed Leard L, Savides T, Ganiats T. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45:211–18.PubMed
40.
go back to reference Nelson R, Schwartz A. A survey of individual preference for colorectal cancer screening technique. BMC Cancer. 2004;4:76.CrossRefPubMed Nelson R, Schwartz A. A survey of individual preference for colorectal cancer screening technique. BMC Cancer. 2004;4:76.CrossRefPubMed
41.
go back to reference Wolf R, Basch C, Brouse C, Shmuckler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health. 2006;96:809–11.CrossRefPubMed Wolf R, Basch C, Brouse C, Shmuckler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health. 2006;96:809–11.CrossRefPubMed
42.
go back to reference Powell A, Burgess A, Vernon S, et al. Colorectal cancer screening mode preferences among US veterans. Prevent Med. 2009;49:442–48.CrossRef Powell A, Burgess A, Vernon S, et al. Colorectal cancer screening mode preferences among US veterans. Prevent Med. 2009;49:442–48.CrossRef
43.
go back to reference McGregor E, Hilsden R, Li F, Bryant H, Murray A. Low uptake of colorectal cancer screening 3 years after release of national recommendations for screening. Am J Gastro. 2007;102:1727–35.CrossRef McGregor E, Hilsden R, Li F, Bryant H, Murray A. Low uptake of colorectal cancer screening 3 years after release of national recommendations for screening. Am J Gastro. 2007;102:1727–35.CrossRef
44.
go back to reference Meissner H, Breen N, Klabunde C, Vernon S. Patterns of colorectal cancer screening uptake among men and woman in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389–94.CrossRefPubMed Meissner H, Breen N, Klabunde C, Vernon S. Patterns of colorectal cancer screening uptake among men and woman in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389–94.CrossRefPubMed
Metadata
Title
What Is Most Important to Patients when Deciding about Colorectal Screening?
Authors
Avlin Imaeda, MD, PhD
Danielle Bender, MD
Liana Fraenkel, MD, MPH
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2010
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1318-9

Other articles of this Issue 7/2010

Journal of General Internal Medicine 7/2010 Go to the issue

Healing Arts

Lasting Sunrise